DRD2 and neuroleptic malignant syndrome: Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal condition characterized by hyperthermia, severe muscle rigidity, altered mental status, and autonomic dysfunction, associated with dopamine D2-receptor antagonists.